switched from semaglutide to tirzepatide and gained weight Comparing for Loss: A Rochester M.D.'s View Switching From Semaglutide To Tirzepatide

While injection timing does not fundamentally alter tirzepatide's side effect profile, strategic scheduling may help patients better manage common adverse effects and maintain treatment adherence

declares having received honoraria from Novo Nordisk, Eli Lilly, Akebia Therapeutics, Ardelyx, Becton Dickinson, Endologix, FibroGen, GSK, Medtronic, Neovasc, Provention Bio, ReCor, BrainStorm Cell Therapeutics, Alnylam and Intarcia for consulting activities, and research funding to his institution from AbbVie, Esperion, AstraZeneca, CSL Behring, Novartis and Eli Lilly

Yes, Wegovy has no absolute upper age limit in the UK, but clinical trial data for patients aged 75 and older are limited

doi:10.1017/s1355617717000534